COVID-19 vaccine close, could be administered to health care workers next week (LIVE UPDATES)

COVID-19 vaccine close, could be administered to health care
workers next week (LIVE UPDATES) 1

Ashlee
Rezin Garcia/Sun-Times

Here’s the latest news on how COVID-19 is impacting Chicago
and Illinois.

Latest
Vaccine close, but Pritzker warns coronavirus precautions
are still key: ‘All I can say is that the virus is
deadly’
 Ashlee
Rezin Garcia/Sun-Times Emilio Cici, 42, of Burr Ridge, gets a shot
as he participates in a clinical trial for a COVID-19 vaccine
developed by UK drugmaker AstraZeneca in the Division of Infectious
Diseases at Rush University Medical Center, Thursday afternoon,
Nov. 19, 2020.

As Illinois’ coronavirus numbers took another step in the
right direction Tuesday, Gov J.B. Pritzker touted the promising
early reviews of the COVID-19 vaccine that could start being
administered to health care workers across the state as early as
next week.

But with daily death counts stuck in the triple digits and a
potential post-Thanksgiving spike still looming, the governor
warned against complacency in the face of the deadly virus — even
with the vaccine in sight.

Once the U.S. Food and Drug Administration gives emergency use
authorization to the Pfizer vaccine as expected Thursday, an
independent state panel will also have to sign off for distribution
in Illinois. But the governor’s health team made clear that the
first shipment of the 95%-effective inoculation will be cast across
Illinois in short order.

Price & Product Availability Tracker

Discover where products are available & compare prices

“Illinois will only distribute a vaccine that is deemed safe,
and we are one of many states that have established additional
review panels,” Pritzker said. “We all want to make sure this
vaccine is safe, and additional sets of eyes on the evidence can
only be helpful.”


Read the full story from Mitchell Armentrout here.

News 11:42 a.m. Canada health regulator
approves Pfizer’s COVID-19 vaccine

TORONTO — Canada’s health regulator on Wednesday approved
Pfizer’s COVID-19 vaccine.

Health Canada posted on it is website that the vaccine made by
U.S. drugmaker Pfizer and Germany’s BioNTech is authorized.

“Canadians can feel confident that the review process was
rigorous and that we have strong monitoring systems in place.
Health Canada and the Public Health Agency of Canada will closely
monitor the safety of the vaccine once it is on the market and will
not hesitate to take action if any safety concerns are
identified,” Health Canada said in a statement.

Canada is set to receive up to 249,000 doses this month and 4
million doses of the vaccine by March.

The department said the vaccine is for use in people 16 years of
age or older, but noted Pfizer-BioNTech are running further
clinical trials on children of all age groups and that could
change.


Read the full story here.

11:40 a.m. UK probing if allergic reactions linked to
Pfizer vaccine

LONDON — British regulators warned Wednesday that people who
have a history of serious allergic reactions shouldn’t receive
the new Pfizer-BioNTech vaccine as they investigate two adverse
reactions that occurred on the first day of the country’s mass
vaccination program.

The U.K.’s Medical and Healthcare Products Regulatory Agency
is looking into whether the reactions were linked to the vaccine.
The two people affected were staff members with the National Health
Service who had a history of allergies, and both are recovering.
Authorities have not specified what their reactions were.

In the meantime, the regulator has issued the warning for anyone
who has had a significant allergic reaction to a vaccine, medicine
or food. That includes anyone who has been told to carry an
adrenaline shot or others who have had potentially fatal allergic
reactions.

“As is common with new vaccines the MHRA have advised on a
precautionary basis that people with a significant history of
allergic reactions do not receive this vaccination after two people
with a history of significant allergic reactions responded
adversely yesterday,’’ Professor Stephen Powis, medical
director for the NHS in England, said in a statement. “Both are
recovering well.”


Read the full story here.

9:09 a.m. The thing about death in the year 2020 is …
it’s not limited to COVID-19

The thing about death in the year 2020 is … it’s not limited
to COVID-19.

In the year of COVID, people you love make their transitions the
same way — socially distanced, with much time since you saw or
even talked to them last, their passing a jolt to your
isolation-addled consciousness, memories left to fade like
beautiful ghosts.

And so it was this weekend, when news came of the passing of two
beloved members of my church family, from cancer, on the same day,
Dec. 3.
Gloria Woods
and
Nathan Clark
were also members of my smaller, close-knit
sub-family, Evanston Area Black Catholics, Inc.

COVID has created a new lifestyle. We are isolated, adapting to
executing our own everyday work and family obligations under the
fears and anxiety 2020 has wrought.

COVID deaths occur in hospitals that are locked down by a
coronavirus cloaked as the grim reaper. It shuts out loved ones and
our opportunity to say goodbye.

But death is still our eventual destination, and COVID hasn’t
changed that.


Read the full story from Maudlyne Ihejirika here.

New Cases

Analysis & Commentary 9:11 a.m. Are
Americans insufficiently alarmed by COVID-19?

Last month, researchers in Texas estimated that nearly 5 million
of the state’s residents had been infected by the COVID-19 virus
— more than four times as many as the official tally of confirmed
cases suggested.

Although the gap implied that the virus was much less deadly
than people initially feared, the Houston Chronicle framed the
prevalence estimate as bad news.

That choice reflects a broader pattern in American press
coverage of the pandemic, which tends to accentuate the negative,
exaggerate risk and ignore encouraging information. The result is
not just depressing but misleading and potentially
counterproductive as Americans are told to keep up their guard
against the virus during the winter they will have to get through
before vaccines are widely available.

Based on an analysis of news stories about COVID-19 that
appeared from Jan. 1 through July 31, Dartmouth economist Bruce
Sacerdote and two other researchers found that 91% of the coverage
by major U.S. media outlets was “negative in tone.” The rate
was substantially lower in leading scientific journals (65%) and
foreign news sources (54%).


Read the full column from Jacob Sullum here.

Read the Full Article

Prepare Now Before its too Late

Discover where products are available & compare prices

In a reversal, California says playgrounds can remain open under COVID-19 restrictions
Canada health regulator approves Pfizer’s COVID-19 vaccine

You might also like
Menu